Gene therapy has emerged as a highly effective and promising approach for treating spinal muscular atrophy, particularly through the delivery of SMN protein to motor neurons, which restores muscle function and prolongs survival (Lin C et al. 2024; Wang J H et al. 2024). This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.